CCJ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cameco looks like a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock has supportive fundamental catalysts, a constructive analyst backdrop, and a recent production recovery story that reinforces the long-cycle uranium thesis. The technical picture is mixed but not weak enough to reject the stock, and the SwingMax signal adds support to entering now rather than waiting. Given the investor profile and impatience for optimal entry, this is a buy.
CCJ closed at 110.86, slightly above the previous close of 110.63, with a strong regular-session gain of 2.97% and a small post-market uptick. MACD histogram is -0.419 but negatively contracting, which suggests bearish momentum is fading. RSI_6 at 57.229 is neutral-to-mildly bullish, and moving averages are converging, indicating a transition phase rather than a strong breakout or breakdown. Price is above pivot 108.009 and below resistance R1 at 113.061, so near-term upside remains available if momentum continues. The stock trend model suggests modest short-term upside, though it flags weaker month-ahead performance.
["Key Lake and McArthur River mines returned to full production after flooding disruptions.", "Cameco reaffirmed its 2026 production outlook.", "Analysts remain broadly constructive on the stock with Buy/Outperform-type ratings continuing.", "Long-cycle demand drivers remain intact from nuclear power, decarbonization, energy security, and reactor/fuel-cycle infrastructure growth.", "SwingMax issued an entry signal on 2026-05-26, supporting a buy-the-dip style entry."]
["GLJ Research lowered its price target, signaling a more cautious near-term setup.", "Options positioning is bearish-leaning based on the 1.33 put-call ratio.", "MACD remains below zero, so the technical trend is not yet fully confirmed as bullish.", "Pattern-based trend data suggests weaker performance over the next month."]
No usable latest-quarter financial snapshot was provided because of a data error, so quarter-over-quarter financial assessment is limited. Based on the available news and analyst commentary, the latest quarter appears to have been operationally supportive, with production restoration and maintained full-year guidance. That points to stable near-term operating momentum, but no direct revenue or earnings growth figures are available here. Latest quarter season not provided.
Analyst sentiment is still favorable overall. GLJ Research recently trimmed its price target to C$152.60 from C$171.20 but kept a Buy rating, while Scotiabank raised its target to $175 from $150 and kept Outperform. CIBC also stayed constructive with an Outperformer rating, and William Blair initiated coverage with Outperform. The trend shows minor target dispersion but persistent bullish ratings. Wall Street pros: strong long-term uranium and nuclear infrastructure exposure, improving fundamentals, and quality franchise. Cons: some analysts are becoming more cautious on the near term, which suggests upside may not be smooth immediately.
